| (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indole | Phase II / Phase III | rekrutiert |
| (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointe | Phase III | rekrutiert |
| - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite S | Phase II | rekrutiert |
| A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disea | Phase IV | rekrutiert |
| A Clinical Study Evaluating the Safety and Efficacy of the VCFix Spinal System for Treatment of | ohne Phasenangabe | rekrutiert |
| A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Followin | Phase III | rekrutiert |
| A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With C | Phase III | rekrutiert |
| A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK- | Phase III | rekrutiert |
| A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Trea | Phase I / Phase II | rekrutiert |
| A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melano | Phase II | rekrutiert |
| A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-724 | Phase II | rekrutiert |
| A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity | Phase III | rekrutiert |
| A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity | Phase III | rekrutiert |
| A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination | Phase I / Phase II | rekrutiert |
| A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Co | Phase II / Phase III | rekrutiert |
| A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world Sett | — | rekrutiert |
| A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Fut | Phase III | rekrutiert |
| A First-in-Human, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of G | Phase I / Phase II | rekrutiert |
| A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia | Phase I / Phase II | rekrutiert |
| A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibros | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head | Phase III | rekrutiert |
| A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradi | Phase III | rekrutiert |
| A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynzi | — | rekrutiert |
| A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Par | Phase II | rekrutiert |
| A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants | Phase III | rekrutiert |
| A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) | Phase III | rekrutiert |
| A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis | Phase II | rekrutiert |
| A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace) | — | rekrutiert |
| A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and You | Phase II | rekrutiert |
| A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesit | Phase III | rekrutiert |
| A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on | Phase II | rekrutiert |
| A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tube | — | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Non-interventional, Prospective Study With Benralizumab | — | rekrutiert |
| A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With De | Phase I / Phase II | rekrutiert |
| A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOV | Phase II | rekrutiert |
| A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermati | Phase II | rekrutiert |
| A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodi | Phase III | rekrutiert |
| A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Throm | Phase III | rekrutiert |
| A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Prev | Phase III | rekrutiert |
| A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treat | Phase III | rekrutiert |
| A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD | Phase III | rekrutiert |
| A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo | Phase III | rekrutiert |
| A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 C | Phase II | rekrutiert |
| A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Sa | Phase III | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of | Phase III | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo i | Phase III | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo i | Phase III | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and | Phase III | rekrutiert |
| A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With | Phase II | rekrutiert |
| A Phase IIb Study to Evaluate AZD8965 in Participants With IPF. | Phase II | rekrutiert |
| A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab P | Phase I | rekrutiert |
| A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treat | Phase III | rekrutiert |
| A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan | Phase III | rekrutiert |
| A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C | Phase III | rekrutiert |
| A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Id | Phase II | rekrutiert |
| A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart | Phase III | rekrutiert |
| A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to | Phase IV | rekrutiert |
| A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar | Phase III | rekrutiert |
| A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD | Phase III | rekrutiert |
| A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multi | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab a | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs | Phase III | rekrutiert |
| A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Do | Phase III | rekrutiert |
| A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple | Phase I / Phase II | rekrutiert |
| A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients W | Phase I | rekrutiert |
| A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Ce | Phase III | rekrutiert |
| A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Her | — | rekrutiert |
| A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinica | Phase II | rekrutiert |
| A Study of AZD0120 in Autoimmune Diseases | Phase I | rekrutiert |
| A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participa | Phase I / Phase II | rekrutiert |
| A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First | Phase III | rekrutiert |
| A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian C | Phase III | rekrutiert |
| A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic | Phase III | rekrutiert |
| A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Adva | Phase II | rekrutiert |
| A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Al | Phase III | rekrutiert |
| A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiop | Phase III | rekrutiert |
| A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone | Phase III | rekrutiert |
| A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin | — | rekrutiert |
| A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagn | Phase III | rekrutiert |
| A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D | Phase II | rekrutiert |
| A Study of Brenipatide in Participants With Alcohol Use Disorder | Phase III | rekrutiert |
| A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder | Phase III | rekrutiert |
| A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adju | Phase III | rekrutiert |
| A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Canc | — | rekrutiert |
| A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treate | — | rekrutiert |
| A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors Wit | Phase I / Phase II | rekrutiert |
| A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanc | Phase III | rekrutiert |
| A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early | Phase III | rekrutiert |
| A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabe | Phase III | rekrutiert |
| A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 D | Phase III | rekrutiert |
| A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulce | Phase II | rekrutiert |
| A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in P | Phase III | rekrutiert |
| A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refra | Phase I | rekrutiert |
| A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults | Phase II | rekrutiert |
| A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapse | Phase III | rekrutiert |
| A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal S | Phase III | rekrutiert |
| A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) | Phase II | rekrutiert |
| A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With | Phase I / Phase II | rekrutiert |
| A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men | Phase III | rekrutiert |
| A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newb | Phase III | rekrutiert |
| A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer | Phase II | rekrutiert |
| A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthriti | Phase III | rekrutiert |
| A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Ca | Phase III | rekrutiert |
| A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cance | Phase III | rekrutiert |
| A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration | Phase III | rekrutiert |
| A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovaria | Phase II / Phase III | rekrutiert |
| A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory M | — | rekrutiert |
| A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NP | Phase I / Phase II | rekrutiert |
| A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tra | Phase III | rekrutiert |
| A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions | Phase II / Phase III | rekrutiert |
| A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab | Phase III | rekrutiert |
| A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With | Phase III | rekrutiert |
| A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoP | — | rekrutiert |
| A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | Phase III | rekrutiert |
| A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-li | Phase III | rekrutiert |
| A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract | Phase III | rekrutiert |
| A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemot | Phase III | rekrutiert |
| A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines | Phase III | rekrutiert |
| A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRI | Phase II | rekrutiert |
| A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy | Phase II | rekrutiert |
| A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzuma | Phase II / Phase III | rekrutiert |
| A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in | Phase I / Phase II | rekrutiert |
| A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the | Phase III | rekrutiert |
| A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin | Phase III | rekrutiert |
| A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to | Phase III | rekrutiert |
| A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PA | Phase II | rekrutiert |
| A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spas | Phase I / Phase II | rekrutiert |
| A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of The | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Parti | Phase III | rekrutiert |
| A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary | Phase I / Phase II | rekrutiert |
| A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chro | Phase II | rekrutiert |
| A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Mo | Phase II | rekrutiert |
| A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-M | Phase III | rekrutiert |
| A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis | Phase II | rekrutiert |
| A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participan | Phase I / Phase II | rekrutiert |
| A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept | Phase III | rekrutiert |
| A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bort | Phase III | rekrutiert |
| A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in P | Phase III | rekrutiert |
| A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants Wi | Phase III | rekrutiert |
| A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplan | Phase III | rekrutiert |
| A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adol | Phase III | rekrutiert |
| A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Ped | Phase III | rekrutiert |
| A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abe | Phase I / Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard | Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experience | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants Wi | Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzhe | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Ol | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab Wit | Phase III | rekrutiert |
| A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients U | ohne Phasenangabe | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Mar | Phase III | rekrutiert |
| A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as | Phase II | rekrutiert |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination | Phase I / Phase II | rekrutiert |
| A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïv | Phase III | rekrutiert |
| A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With | Phase III | rekrutiert |
| A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Childre | Phase III | rekrutiert |
| A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Foc | Phase III | rekrutiert |
| A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by | Phase III | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis | Phase II | rekrutiert |
| A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participant | Phase III | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Par | Phase III | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared | Phase III | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Pl | Phase III | rekrutiert |
| A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in A | Phase III | rekrutiert |
| A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Part | Phase II | rekrutiert |
| A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Th | Phase I / Phase II | rekrutiert |
| A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients Wit | Phase III | rekrutiert |
| A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Wh | Phase II | rekrutiert |
| A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in | Phase III | rekrutiert |
| A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely | Phase III | rekrutiert |
| A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resista | Phase III | rekrutiert |
| A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Tak | Phase III | rekrutiert |
| A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How i | Phase III | rekrutiert |
| A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Child | Phase III | rekrutiert |
| A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 | Phase II | rekrutiert |
| A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout t | Phase I | rekrutiert |
| A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prosta | Phase II | rekrutiert |
| A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosu | Phase III | rekrutiert |
| A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Fa | Phase III | rekrutiert |
| A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia | Phase III | rekrutiert |
| A Trial to Assess the Efficacy and Safety of Obinutuzumab in Treating Adults With Minimal Change | Phase II | rekrutiert |
| A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalid | Phase III | rekrutiert |
| ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or | Phase I / Phase II | rekrutiert |
| ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Defic | Phase II | rekrutiert |
| AID-FOG: Artificial Intelligence-Driven Freezing of Gait Detection in the Home | — | rekrutiert |
| AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Ex | Phase III | rekrutiert |
| AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Exc | Phase III | rekrutiert |
| AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Exc | Phase III | rekrutiert |
| APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter Study | ohne Phasenangabe | rekrutiert |
| ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With | Phase III | rekrutiert |
| AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple My | Phase I / Phase II | rekrutiert |
| AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia | Phase I / Phase II | rekrutiert |
| AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platin | Phase III | rekrutiert |
| Abbott DBS Post-Market Study of Outcomes for Indications Over Time | — | rekrutiert |
| Ablation of Consecutive Atrial Tachycardia | ohne Phasenangabe | rekrutiert |
| Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL | Phase III | rekrutiert |
| Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At | Phase II | rekrutiert |
| Additional Left Atrial Appendage Isolation During Balloon Ablation for Persistent or Long-standi | ohne Phasenangabe | rekrutiert |
| Adjuvant Tebentafusp in High Risk Ocular Melanoma | Phase III | rekrutiert |
| Adolescent Psychiatry Inpatients: Self-reported Parent-adolescent Communication Quality and Trea | — | rekrutiert |
| Affera Global Registry | — | rekrutiert |
| Alert Frequency, Nurse, and Patient Satisfaction With a wCVSM Software Across Health Care System | — | rekrutiert |
| Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leuka | Phase II / Phase III | rekrutiert |
| An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients Wi | ohne Phasenangabe | rekrutiert |
| An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma | Phase II / Phase III | rekrutiert |
| An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical | — | rekrutiert |
| An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-ter | Phase III | rekrutiert |
| An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Pa | Phase II | rekrutiert |
| An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Stud | Phase III | rekrutiert |
| An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in | Phase III | rekrutiert |
| Analysis of Safety and Tissue Interaction of Injectable Biosmulators | ohne Phasenangabe | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis | Phase III | rekrutiert |
| Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting | ohne Phasenangabe | rekrutiert |
| Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipopr | Phase III | rekrutiert |
| Assessment of Infection Activity in Travelers and Migrants Diagnosed With Chronic Schistosomiasi | ohne Phasenangabe | rekrutiert |
| Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIA | — | rekrutiert |
| Awake Prone Positioning in Spontaneous Breathing Patients With Acute Hypoxic Respiratory Failure | ohne Phasenangabe | rekrutiert |
| BEAM-MM - β-Hydroxybutyrate-Enhanced Adaptive Immunity in Multiple Myeloma | ohne Phasenangabe | rekrutiert |
| BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatmen | — | rekrutiert |
| BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF | ohne Phasenangabe | rekrutiert |
| Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination Wit | Phase I / Phase II | rekrutiert |
| Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With | Phase II | rekrutiert |
| Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseContr | ohne Phasenangabe | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| Biomarkers in Acute Cardiac Care | — | rekrutiert |
| Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic C | Phase III | rekrutiert |
| BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT | ohne Phasenangabe | rekrutiert |
| Brain Signal Training to Enhance Affect Down-regulation | Phase I / Phase II | rekrutiert |
| CAR-T Long Term Follow Up (LTFU) Study | Phase III | rekrutiert |
| CArdioSurgEry Atrial Fibrillation Register | — | rekrutiert |
| CEDUR - German IBD Registry | — | rekrutiert |
| CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry | — | rekrutiert |
| COCONUT Study Concomitant PVI and LAAC | — | rekrutiert |
| COMS for Chronic Ulcers Treatment | Phase IV | rekrutiert |
| Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello- | Phase III | rekrutiert |
| Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer | Phase II | rekrutiert |